Sudemycin D1, another inhibitor of SF3B1, modulated the splicing of several genes including MCL-1, both in SF3B1-mutated and wild-type CLL cells, although this effect was validated exclusively at the mRNA level [57]. Here, MCL1 is linked to B-cell chronic lymphocytic leukemia.